Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga] MDM2/MDMX Peptide PET Imaging in Solid Tumors
NCT06443762Phase 1Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2025
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Standardized Uptake Value at 2 hours. Started Jan 2025; status: completed.
Beyond the preview
Go deeper on NCT06443762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06443762.